ImageneBio (IMA) Minority Interest (2024)
ImageneBio (IMA) posted Minority Interest of $159.0 million for Q4 2024.
ImageneBio (IMA) Minority Interest (2024) Analysis & Trends
ImageneBio has reported Minority Interest for 1 years, with the latest figure at $159.0 million in Q4 2024.
- Quarterly Minority Interest changed N/A year-over-year to $159.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $159.0 million (changed N/A YoY) and the FY2024 annual result came in at $159.0 million, changed N/A from the prior year.
- Minority Interest was little changed at $159.0 million in Q4 2024 per IMA's latest filing.
- Over five years, Minority Interest peaked at $159.0 million in Q4 2024 and troughed at $159.0 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.01 Bn | 132.16 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.79 Bn | 78.79 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn |
| 4 | Moderna | 60.18 Bn | 55.04 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.55 Bn | 28.24 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.45 Bn | 10.06 Bn | 668.28 Mn |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.19 Bn | 26.36 Bn | - |
| 10 | ImageneBio | 48.35 Mn | -87.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 159.04 Mn |